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The detection of growth hormone (GH) and its receptor in germinal regions of the mammalian brain
prompted our investigation of GH and its role in the regulation of endogenous neural precursor cell activity.
Here we report that the addition of exogenous GH significantly increased the expansion rate in long-term
neurosphere cultures derived fromwild-typemice, while neurospheres derived fromGHnullmice exhibited
a reduced expansion rate. We also detected a doubling in the frequency of large (i.e. stem cell-derived)
colonies for up to 120 days following a 7-day intracerebroventricular infusion of GH suggesting the
activation of endogenous stem cells. Moreover, gamma irradiation induced the ablation of normally
quiescent stem cells in GH-infused mice, resulting in a decline in olfactory bulb neurogenesis. These results
suggest that GH activates populations of resident stem and progenitor cells, and therefore may represent a
novel therapeutic target for age-related neurodegeneration and associated cognitive decline.
I
t is now clear that the adult mammalian brain contains populations of endogenous neural stem1,2 and
progenitor cells (together termed precursor cells) that have the ability to replace lost populations of cells
under normal conditions3 and can become activated after injury4,5. Stem cells are best defined by their ability to
proliferate, self-renew over an extended period of time, and generate a large number of differentiated progeny6,7.
While this functional definition is accurate, it unfortunately restricts investigators to a retrospective analysis. This
degree of uncertainty hasmade the identification of neural stem cells (NSCs) a controversial area of research since
their discovery1. Coincident with the investigation of NSC biology using functional assays was the pioneering
work of Alvarez-Buylla and colleagues8,9 which elegantly described the cytoarchitecture and cellular hierarchy of
the adult subventricular zone (SVZ) of the lateral ventricle; one of two locations within the adult mammalian
brain known to contain NSCs and their progeny. As recently reviewed by Kreigstein and Alvarez-Buylla10, NSCs
in this region (termed Type B cells) proliferate to produce transient amplifying cells (Type C cells) that in turn
generate migratory neuroblasts (Type A cells). It is these Type A cells that ultimately repopulate lost populations
of interneurons in the olfactory bulb (OB) via the rostral migratory stream (RMS).
There is now a growing list of NSC markers that have been reported to localize with Type B cells such as glial
fibrillary acidic protein (GFAP)11,12, Nestin13, CD13314 and platelet derived growth factor receptor alpha
(PDGFRa)15,16. Unfortunately, as these markers are not found exclusively on NSCs, investigators continue to
use a multifaceted approach, combining the use of these markers with functional studies to more confidently
identify neural stem and progenitor cells in vivo17. Indeed, previous studies have used the neurosphere assay to
assess stem and progenitor cell numbers and have shown that both type B and C cells have the ability to form
neurospheres19,20 making it difficult to discriminate between the two populations. Fortunately, an in vivo culture
technique, the neural colony forming cell assay (N-CFCA), has recently been developed whereby colony size
enables the discrimination between NSC- and progenitor-derived colonies21. Studies employing this new tech-
nique have reinforced the hypothesis that Type C cells do not appear to possess the extensive self-renewal
capabilities typically observed in populations of NSCs22–25.
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In addition to phenotypic identification, understanding howNSCs
and progenitor populations are activated is of considerable import-
ance. While best known for its role in regulating somatic growth and
metabolic processes, there is substantial evidence to suggest that
growth hormone (GH) plays an important role in the development
and repair of the mammalian central nervous system26–29. For ex-
ample, GHR null (GHR2/2)30 and Suppressor of Cytokine Signaling-
2 knockout mice, which represent loss and gain of GHR function
respectively, display altered brain size, cortical architecture, and
neuron and glial cell number31,32. Moreover, GH administration
improves cognitive deficits in GH-deficient rodents33,34, and acts as
a neuroprotective agent in aged animals35.
Prior work describing the widespread expression of GH and GHR
in the perinatal and adult rat brain36–39, the ability of GH to cross the
blood brain barrier40,41, and its ability to act as a neuroprotective
agent when infused directly into the ventricles of rodents after
stroke27 suggests GH acts directly on neural cells. Building on these
findings, more recent in vitro studies have demonstrated that the
addition of exogenous GH increases the frequency of both rodent-42
and human-derived neurospheres43. Moreover, neurospheres gener-
ated fromGHR2/2mice appear smaller, contain fewer proliferating
cells, and exhibit reduced self-renewal42. These results clearly dem-
onstrate that GH is acting on neural precursors, but do not directly
address whether a functional GHR is found on NSCs. Although, the
detection of GH and GHR-immunoreactive (GHR1ve) cells in ger-
minal regions of the adult brain highly enriched in precursor cells32,38
and our recent observation of an absence of exercise-dependent
enhancement of NSC number in the SVZ of adult GHR2/2 animals24
further suggests the GH/GHR pathway plays a direct role in activ-
ating endogenous NSCs. Accordingly, we sought to directly invest-
igate whether a functional GHR is present on resident neural stem
and progenitor cells in the adult mouse brain and determine whether
it is able to regulate the activity of these cells.
Results
GHR1ve cells exhibiting stem cell properties are present in ger-
minal regions of the mouse brain. Consistent with prior studies in
the rat using in situ hybridization38,39, GHR1ve cells (i.e. those
immunoreactive for sc-20747Ab, which labels the intracellular
portion of the receptor) were detected both in the adult SVZ
surrounding the lateral ventricles and in the dorsolateral corner of
the lateral ventricles. Using double-label immunocytochemistry we
detected a population of GHR1ve cells within the SVZ that localized
with markers typically found on endogenous stem/progenitor cells,
namely CD13314,44 (Fig. 1A–C) and GFAP (Fig. 1D–F). GHR1ve cells
also localized with the mitotic cell marker Ki6745 (Fig. 1G–I), the
immature neuronal marker doublecortin46 (Dcx; Fig. 1J–L) and
PSA-NCAM (polysialic acid-neuronal cell adhesion molecule,
Fig. 1M–O), a known marker of migrating neuroblasts destined for
the OB47.
As these results suggest that a GHR is found on a subpopulation of
neural precursor cells, we next employed two functional assays; the
neurosphere assay1 and N-CFCA21 to confirm that GHR was indeed
located on neural stem and progenitor cells. Accordingly, the peri-
ventricular region (PVR), which we define as tissue including the
ependymal cell layer, SVZ and the immediately surrounding par-
enchyma, was harvested (bilaterally), enzymatically brought to a
single cell suspension, immunostained for GHR, and then sorted
directly into 35 mm dishes containing complete neurosphere med-
ium. As sc-20747Ab labels the intracellular portion of the receptor, a
second antibody against the extracellular portion48 was used for all
subsequent experiments. Consistent with our detection of GHR1ve
cells in the adult SVZ, flow cytometric analysis of tissue harvested
from the same region revealed a distinct population of viable GHR1ve
cells (Fig. 2A and B). When plated in neurosphere-generating con-
ditions, 1 in every 112623.0 (mean6SEM, N53) cells from the
GHR1ve population was able to generate a primary neurosphere.
As an extra confirmation step that the sorted population of
GHR1ve cells obtained possessed GHR, transcripts for the receptor
by PCR were compared between the positive and negative cell popu-
lations (Note: the relative expression level was to the internal ref-
erence gene GADPH). Markedly increased expression levels relative
to sorted GHR2ve cells were observed (Fig. 2C) confirming the reli-
ability of the antibody.
As primary neurosphere formation does not demonstrate the
presence of a NSC per se20,21, individual clonally-derived neuro-
spheres generated from GHR1ve sort population were enzymatically
dissociated and serially passaged every 7 days to demonstrate their
self-renewal potential. To demonstrate multipotency, neurospheres
Figure 1 | Distribution and phenotype of GHR1ve cells in the adult SVZ.
GHR1ve cells were detected scattered throughout the SVZ surrounding the
lateral ventricle. These cells co-expressed the stem cell markers CD133 (A–
C) and GFAP (D–F), as well as the cell proliferation marker Ki67 (G–I).
GHR1ve cells were also detected in the dorsolateral corner of the lateral
ventricle localized withDcx (J–L) and PSA-NCAM (M–O). DAPIwas used
to label the nucleus (Blue in merged images) Omission of primary
antibody resulted in loss of immunoreaction. Scale bar: 5 10 mm.
www.nature.com/scientificreports
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were harvested at the 5th passage and transferred to differentiating
conditions for a period of 7 days. These differentiated spheres were
then fixed and processed for triple-antigen immunoreactivity against
bIII-tubulin (neurons), GFAP (astrocytes), and O4 (oligodendro-
cytes). All three cell types were simultaneously detected in 91% of
the 188 GHR1ve cell-derived spheres examined (Fig. 2D). Taken
together, these data demonstrate that a subpopulation of GHR1ve
cells harvested from the adult SVZ exhibits all of the cardinal func-
tional properties of a NSC in vitro, suggesting that GH-responsive
NSCs are present in the adult SVZ.
Addition of GH increases stem cell frequency in vitro. To
determine whether exogenous GH alters the proliferative activity
of NSCs in vitro, we generated neurosphere cultures from wild-
type (WT) adult PVR tissue and serially subcultured the cells in
the continued presence of epidermal growth factor (EGF) or EGF
supplemented with GH (EGF1GH). The number of cells generated
at each passage was recorded, and the rate of expansion calculated.
By log transforming the cumulative number of cells produced as a
function of time for each of the cultures and applying linear
regression analysis, we found that the addition of GH resulted in a
significantly (p,0.01) increased slope as compared to that generated
by cells cultured in EGF alone (Fig. 3A). Given that changes to the
rate of expansion over long-term culture can only be attributed to a
self-renewing population49, these results suggest GH-supplemented
cultures are characterized by a greater NSC frequency than those
cultured in EGF alone.
However, to confirm that a greater number of stem cells were
present in GH-stimulated cultures, neurosphere-derived cells were
harvested at passage five, and cultured in the N-CFCA in the pres-
ence of EGF alone. Unlike the neurosphere assay, which does not
allow for discrimination between stem and more restricted progen-
itor cells20,21,23,24, NSC-derived colonies can be identified from non-
NSC-derived colonies in the N-CFCA on the basis of size. Only cells
comprising the largest colonies (i.e. those .2.0 mm in diameter,
demonstrating the highest replicative potential) exhibit the cardinal
properties of bona fide NSCs in vitro21. Thus, by enumerating large
colonies .2.0 mm, as compared to those ,2.0 mm, a measure of
stem versus progenitor cell numbers, respectively, can be obtained19,25.
Consistent with the long-term expansion data (Fig. 3A), after
3 weeks in vitro, those neurosphere-derived cells passaged in
EGF1GH generated a significantly greater number of large (i.e.
NSC-derived) colonies, as compared to those passaged in EGF alone
(Fig. 3B; p # 0.01). Importantly, no significant difference was
detected in the number of progenitor cell-derived colonies in EGF
versus EGF1GH conditions, suggesting that GH acts directly on
NSCs. It should be noted that exogenous bFGF was absent from all
culture conditions either in the originalmedia or during the course of
the culture period.
Deletion of GHR in vivo reduces the number of NSCs in vitro. As
GHR stimulation increased the number of NSCs in vitro, we next
determined whether deletion of the receptor in vivo resulted in the
generation of fewer NSCs. Accordingly, long-term neurosphere
cultures were generated from adult GHR2/2 mice (which lack a
functional GHR due to the targeted deletion of the mouse GHR/
GHBP gene30), and littermate controls. GHR deletion resulted in
significantly decreased slope in the neurosphere assay as compared
to cultures from littermate controls (Fig. 3C; p,0.01). Furthermore,
when cells from these mice were harvested at passage 5 and cultured
in the N-CFCA, significantly fewer NSC-derived colonies were
detected from GHR2/2 cultures compared to controls (Fig. 3D;
p,0.01). Of note, neurosphere-derived cells harvested from
GHR2/2 mice also generated significantly fewer progenitor cell-
derived colonies as compared to littermate controls (p,0.01).
Fewer endogenous stem and progenitor cells are present in
GHR2/2 mice. To determine whether GHR2/2 mice have fewer
endogenous stem and progenitor cells, we next cultured cells
harvested cells from the PVR of adult GHR2/2 mice and cultured
them directly in the N-CFCA without an intermediate neurosphere
culture step. We found that significantly fewer NSC-derived
(p,0.01) and progenitor cell-derived (p,0.05) colonies were
generated from GHR2/2 mice than from littermate controls
(Fig. 4A). A significant reduction in the number of progenitor cell-
derived colonies was not unexpected here, given our previous
observation of a reduction in the number of primary neurospheres
from adult GHR2/2 mice compared to controls.
Acute infusion of GH results in a long-term increase in NSC
number. To complement the loss-of-function data, we next
infused GH (5 ng/hour) directly into the lumen of the lateral
ventricle of WT mice for 7 days, and then harvested PVR tissue 3
days after completion of the infusion, and cultured the resulting
single cell suspension directly in the N-CFCA. Consistent with the
in vitro actions of exogenous GH (Fig. 3A and B), GH infusion
resulted in a significant increase in the number of NSC-derived
colonies (p,0.01) with no significant change in the number of
progenitor cell-derived colonies (p.0.05) as compared to saline-
infused controls (Fig. 4B).
Figure 2 | GHR-IR cells represent a distinct population of cells that
exhibit extensive proliferation and self-renewal in vitro. Dot plot of cells
harvested from the PVR of adult mice incubated with secondary alone (PE
conjugated goat-anti-rabbit IgG) (A) or anti-mouse GHR (B) reveals a
distinct population of viable GHR1ve cells comprising 0.2960.03%
(mean6SEM, n5 9) of the total population. High powermagnification of
a typical GHR-IR cell illustrates the punctate nature of labeling (Inset, B).
(C) Relative expression levels of GHR transcript to GADPH inGHR1ve and
GHR2ve sort populations harvested from adult SVZ (n 5 3 independent
experiments, mean 6 SEM). (D) Individual clonally derived neurospheres
from sorted GHR1ve cells are multipotent, generating neurons (red, b-III-
tubulin), astrocytes (blue, GFAP), and oligodendrocytes (green, O4). Scale
bar 5 10 mm.
www.nature.com/scientificreports
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To determine whether the GH-dependent activation of endogen-
ous precursor cells was transient, as observed with the ICV infusion
of basic fibroblast growth factor (bFGF) (Fig. 4C), we harvested and
cultured PVR tissue from GH-infused mice over increasing survival
periods following the 7-day infusion. Surprisingly, we observed a
significantly greater number of large colonies at 21 (p,0.01), 48
(p,0.01), 60 (p,0.05), and 120 days (p,0.01) after pump place-
ment (compared to saline-infused controls), demonstrating a unique
long-term effect of GH in the activation of endogenous NSCs
(Fig. 4D).
Endogenous NSCs are activated in the SVZ following GH in-
fusion. It is possible that the long-term increase in the number of
large (i.e. NSC-derived) colonies following GH infusion reflects a
peculiarity of the N-CFCA, and not a bona fide increase in the
number of endogenous NSCs. We therefore adopted an in vivo
ablation/regeneration approach to distinguish between these two
possibilities. Ablation of the dividing cells within the SVZ can be
achieved either by the infusion of anti-mitotic agents directly into
the ventricle50 or by exposing the brain to ionizing or x-irradiation51,52.
Given their quiescent nature, NSCs are considered to be largely
spared by this process2 as evidenced by efficient regeneration of the
region post-irradiation. We reasoned that if GH infusion was acti-
vating normally quiescent NSCs to divide, then exposure to ionizing
radiation after GH infusion would ablate the GH-responsive dividing
NSCs, resulting in an incomplete repopulation of the region.
Accordingly, GH- and saline-infused mice were exposed to a sin-
gle dose of ionizing radiation (3.5 Gy) 14 days after pump removal,
and then sacrificed at increasing chase periods. We tracked the
repopulation of all dividing cells in the region of the ventricles har-
vested in a typical SVZ dissection (i.e. 12.54 to 10.94 in relation to
Bregma) by administering a single injection of BrdU (45 mg/kg body
weight) to GH- and saline-infused mice 2 hours prior to sacrifice.
Compared to saline-infused controls, significantly fewer BrdU-
immunoreactive (BrdU1ve) cells were detected in the SVZ of GH-
infused mice at 1-, 2- and 3-week (p,0.01) survival time points
(Fig. 5A), reflecting an incomplete repopulation of the region, pre-
sumably due to the irradiation-induced loss of NSCs activated in
response to GH infusion2,52.
To more directly demonstrate that a single 3.5 Gy dose of
irradiation spared the NSC population, a cohort of wild-type
animals was irradiated 5 hours prior to sacrifice and compared to
Figure 3 | Addition of exogenous GH increases NSC numbers, while deletion of GHR reduces NSC frequency in long-term neurosphere cultures.
(A) Linear regression analysis of the total number of cells generated after each passage in adult SVZ-derived long-termneurosphere cultures grown in EGF
(20 ng/ml) or EGF supplemented with GH (EGF1GH; 100 ng/ml) reveals that the addition of GH results in a significantly increased rate of expansion
(i.e. slope) as compared to neurospheres cultured in EGF alone (p 5 0.008; n 5 3, Student’s t-test). (B) When transferred to the N-CFCA, neurosphere-
derived cells passaged in EGF1GH generated significantly more NSC-derived colonies as compared to those passaged in EGF alone (13.061.0 vs. 761.2,
n5 3, p5 0.011, Student’s t-test), without affecting the overall number of progenitor cell-derived (,2.0 mm) colonies. (C) In contrast, linear regression
analysis of the number of cells generated after each passage in long-term neurosphere cultures generated from the PVZ demonstrates a significantly
reduced rate of expansion in adult GHR2/2 (p,0.0001, n 5 4) as compared to control. (D)When transferred to the N-CFCA, neurosphere-derived cells
fromGHR2/2 mice generated significantly fewer large colonies, as compared to those derived from controls (2.2560.75 vs. 8.2560.75, n5 4, p5 0.0013,
Student’s t-test). The number of progenitor cell-derived colonies (218.3620.3 vs. 315.8613.7, n54, p 5 0.0072) were also significantly reduced in
GHR2/2 mice as compared to littermate controls. *p,0.05, **p,0.01.
www.nature.com/scientificreports
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non-irradiated animals. When PVR tissue was harvested from these
mice and cultured directly in the N-CFCA, we observed a significant
(p,0.01) decrease in the number of progenitor cell-derived colonies
(Fig. 5B). However, consistent with the sparing of a relatively qui-
escent population of NSCs, we failed to observe a change in the
number of NSC-derived colonies between control and irradiated
animals (Fig. 5B; 127.3622.9 vs. 129.365.5, respectively).
Therefore, to complement our in vivo finding of an incomplete
repopulation of BrdU1ve cells in the SVZ of GH-infused mice
(Fig. 5A), we next repeated the ablation/repopulation approach using
the reappearance of neurosphere-forming cells as an additional in
vitro readout of SVZ repopulation. We included two additional
cohorts of mice to provide support for our hypothesis that the
incomplete repopulation effect was due to the GH-induced activa-
tion (and subsequent radiation-induced ablation) of endogenous
NSCs. One cohort received a 7-day ICV infusion of EGF (20 ng/ml;
a treatment we previously demonstrated stimulates endogenous pro-
genitor cell proliferation, leaving NSC number unchanged53) 14 days
prior to irradiation to demonstrate that ablation of mitotically-active
progenitor cells does not have the same detrimental effect on SVZ
repopulation. A second cohort of mice received an additional dose of
irradiation (3.5 Gy) 2 days prior to normal irradiation. These ‘‘dou-
ble-dose’’ mice were employed based on the observation by
Morshead and colleagues that normally quiescent NSCs (which were
activated in response to the initial ablation of dividing cells) could be
ablated by subjecting the mice to a second ‘‘kill’’ 2 days following the
initial ablation2. Having demonstrated (Fig. 5A) that a single dose of
ionizing radiation was sufficient to ablate dividing cells, largely spar-
ing and then activating quiescent NSCs (as evidenced by the prev-
iously reported efficient repopulation of the region2,50 and our work
here, see Fig. 5B), we reasoned that the ‘‘double-dose’’ approach of
NSC ablation would mimic GH-infused animals, where a substantial
proportion of NSCs were GH-activated prior to irradiation.
As expected fromprevious reports51,52 the number of neurosphere-
forming cells in saline-infused mice was reduced to approximately
60% of normal (i.e. the number of cells present in non-irradiated
(T0) animals), 24 hours following irradiation, rebounding to supra-
control levels in the period following ablation (Fig. 5C). Interestingly,
although EGF-infused mice generated significantly more neuro-
spheres immediately prior to irradiation (T0, p,0.01), and displayed
a more rapid SVZ repopulation post-irradiation compared to con-
trols (1 vs. 3 weeks, respectively), no significant difference in the
number of neurospheres generated by 6 weeks post-irradiation was
observed in the EGF-infused mice compared to the controls, reflect-
ing complete repopulation of the region. In contrast, the repopu-
lation of the SVZ in both ‘‘double-dose’’ and GH-infused mice was
Figure 4 | Fewer NSCs are detected in the PVR of adult GHR2/2mice, while an acute ICV infusion of GH into wild-type mice results in a long-term
increase in endogenous NSCs. (A) PVR cells harvested from adult GHR2/2 mice generate significantly fewer NSC-derived colonies (15.062.9 vs.
30.662.1, n 5 4, p 5 0.0066) and progenitor cell-derived colonies, as compared to littermate controls (158.365.5 vs. 266.3625.7, n 5 4, p 5 0.017).
(B) Cells harvested from the PVR of GH-infused mice 10 days from the onset of infusion generate a significantly greater number of stem cell-derived
colonies compared to vehicle-infused control mice (17.163.0 vs. 7.161.4, n 5 9, p5 0.004), with no associated change in the number of progenitor cell-
derived colonies (311.6649.5 vs. 228.8613.8, n 5 9, p5 0.127). (C) Ten days after bFGF infusion, the number of progenitor (253.967.2 vs. 467637.9, n
5 5, p5 0.002) andNSC-derived colonies (5.560.33 vs. 17.861.3, n5 5, p5 0.0001) was significantly increased relative to saline-infused controls. After
21 days of the bFGF infusion, however, the number of NSC-derived (4.660.8, p5 0.643, n54) and progenitor cell-derived (247617.1, n 5 4, p5 0.060)
colonies returned to levels similar to that of saline-infused controls. (D) The number of NSC-derived colonies remained significantly increased at 21 days
(12.860.7, n 5 6, p 5 0.009), 48 days (14.161.4, n 5 6, p 5 0.003), 60 days (13.161.8, n 5 6, p 5 0.021) and 120 days (13.660.7, n 5 6, p 5 0.004)
following the onset of GH infusion as compared to vehicle-infused controls (7.161.4, n 5 9, p 5 0.0038). *p,0.05, **p,0.01, Student’s t-test.
www.nature.com/scientificreports
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severely compromised, with sphere-forming cells remaining signifi-
cantly reduced in these cohorts, as compared to saline controls 3
weeks post-ablation (p,0.01) and pre-irradiation levels (p,0.01).
Indeed, repopulation of GH-infused mice remained static between 3
and 6 weeks post-irradiation.
GH-induced increase in SVZ NSCs augments adult neurogenesis.
Considering the known contribution of SVZ stem and progenitor
cells to OB neurogenesis, we next investigated how GH infusion
affected the frequency of GH-responsive cell types in the SVZ, and
whether the GH-dependent increase in SVZ NSCs increased OB
neurogenesis. Accordingly, brains were removed from GH-infused
mice 10 and 21 days after the onset of a 7-day ICV infusion, sectioned
(14 mm), and processed for double-label immunocytochemisty to
detect GHR1ve cells from the onset of the lateral ventricles to the
level of the anterior commissure (i.e. 11.42 to 0.14 mm rostral to
Bregma). We failed to detect any change in the overall frequency of
GHR1ve cells in the PVR surrounding the lateral ventricles or the
dorsolateral corner of the ventricle at either 10- (1282656) or 21-day
(1084617) survival times, compared to naı¨ve mice (1098647).
However, the frequencies of four subsets of GHR1ve cells (those
expressing putative NSC antigens) did increase transiently at 10
days, returning to basal levels by 21 days. These included GHR1ve/
Ki671ve (7266 to 11166, p 5 0.01, n 5 3), GHR1ve/Nestin1ve (6265
to 10067, p,0.01, n 5 3), and GHR1ve/CD1331ve (184615 to
21969, p,0.05, n 5 3) cells in the PVR surrounding the ventricle,
and GHR1ve/PSA-NCAM1ve (474612 to 594640, p,0.05, n 5 3)
cells in the dorsolateral corner of the ventricle.
Although these results suggest that GH infusion increases the
frequency of migrating neuroblasts; to more accurately determine
whether the GH infusion alters the number of new neurons being
generated in the OB, and whether this is a NSC-related effect, two
final experiments were performed. In the first experiment, GH-
infused mice were given a single i.p. injection of BrdU (45 mg/kg
body weight) 7 days after GH pump placement and sacrificed after a
28-day chase period, providing sufficient time for newly generated
cells tomigrate to theOB and differentiate into neurons. The number
of newly generated cells reaching the OB (i.e. BrdU1ve) and newly
differentiated neurons (i.e. BrdU1ve/NeuN1ve) was determined by
examining tissue sections through the entire OB. While GH did
not alter the overall number of migrating cells reaching the OB
(BrdU, Fig. 6A), it did significantly increase the number of new
neurons (BrdU/NeuN, p,0.01, n 5 3).
In the second experiment to determine whether radiation ablation
of GH-activated NSCs would also result in a significant decline in
OB neurogenesis, a cohort of mice received a 7-day ICV infusion of
GH, followed by a single dose (3.5 Gy) of irradiation 7 days later.
Twelve days after the end of the infusion, these mice were adminis-
tered one i.p. injection of BrdU every 2 hours until five injections
were given. Multiple injections of BrdU were employed to ensure a
meaningful number could be detected following the irradiation-
induced ablation of the majority of dividing cells. Twenty-eight
Figure 5 | Repopulation of the PVR is significantly compromised in GH-
infused mice. (A) Significantly fewer BrdU1ve cells were detected in the
PVR of GH-infused mice as compared to saline-infused controls at 1 (p 5
0.0016), 2 (p 5 0.0047) and 3 weeks (p 5 0.0044) after a single does of
irradiation (n53 for all treatments). (B) There was a decrease in the total
number of colonies from PVR harvested from wild-type non-irradiated
compared to wild-type 3.5Gy irradiated animals five hours post-
irradiation (15236136.8 vs. 829664.9, n 5 3, p 5 0.01), however, there
was no change in the number of NSC-derived colonies (127.3622.9 vs.
129.365.5, n 5 3). (C) Number of neurospheres generated from adult
PVR tissue harvested from saline- (???), EGF- (???), GH-infused (???), and
‘‘double-dose’’ (???) mice immediately prior to irradiation (T0), and at
increasing survival times following irradiation. As compared to control
(1815.8667, n 5 6), only EGF-infused mice generated significantly more
neurospheres at T0 (2672679, p 5 0.002). At 24 hours post-irradiation,
PVR tissue from GH-infused (p 5 0.002) and Double (Dbl) dose (p 5
0.0002) mice generated significantly fewer neurospheres than controls. By
1 week post-irradiation the number of neurospheres generated from both
GH (300644) and Dbl dose mice (23669) remained significantly reduced
(p5 0.0004 and 0.007, respectively) as compared to control (1318656). In
contrast, EGF-infused mice generated significantly more neurospheres
(2358672) compared to controls at both T0 (p 5 0.003) or 1 week post-
irradiation (p,0.001). By 6 weeks, the number of neurospheres generated
from EGF-infused (1797629) andDbl dosemice (1746685) did not differ
from controls (14166157), while GH-infused mice continued to generate
significantly fewer neurospheres (888666, p,0.05). Significance relative
to saline control. N53 unless otherwise stated. *p,0.05, **p,0.01.
www.nature.com/scientificreports
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days after the irradiation, the mice were sacrificed. As illustrated in
Figure 6B, and consistent with our observation of a significant
increase in GHR1ve/PSA-NCAM1ve cells in the RMS following GH
infusion, the number of BrdU1ve cells reaching the OB was signifi-
cantly reduced (p,0.01, n 5 3) as compared to saline-infused con-
trols. Moreover, the number of newly generated neurons was also
significantly reduced in GH-infused mice (p,0.05, n 5 3). Taken
together, these results demonstrate that in addition to its NSC-
stimulatory effect, GH also regulates the number of new neurons
destined for the OB in adult mice.
Discussion
In light of its importance in neural development26, its role in the
exercise-induced increase in NSCs24 and our detection of GHR1ve
cells in the PVR of the adult brain32,38, we hypothesized that a func-
tional GHR is present on a population of NSCs, where it regulates the
activity of these cells both in vitro and in vivo. Consistent with this
hypothesis is our recent demonstration that while insufficient to
generate neurospheres, GH functions as an autocrine mitogen, aug-
menting the proliferation of adult neurosphere cultures42. However,
given only a minority of neurospheres are NSC-derived, these results
do not address whether GHRs are present on NSCs, or whether they
regulate NSC activity directly.
In contrast, our demonstration here of a reduced rate of expansion
of long-term neurosphere cultures generated fromGHR2/2 mice and
reduced numbers of NSC-derived colonies (as compared to WT
littermates), together with our observation that GH increases the rate
of expansion and the number of NSC-derived colonies generated
from long-term neurosphere cultures, now provides direct evidence
of a regulatory role for GH/GHR on adult NSCs in vitro. Further-
more, we have shown that GHR1ve cells in the PVR of adult mice
localize with the NSC markers GFAP11,12 and CD133 (which is coex-
pressed withmusashi and SOX-1/-244), and when sorted directly into
neurosphere generating conditions, GHR1ve cells from the PVR ex-
hibit the cardinal stem cell attributes of proliferation, self-renewal
and the ability to generate differentiated progeny (Fig. 2). Taken
together, these results demonstrate the presence of GHR on a popu-
lation of cells in vivo, whose phenotypic and functional attributes are
consistent with those of NSCs.
The inability of BrdU-label retention to discriminate NSCs from
more restricted proliferative progenitors19, the absence of selective
positive markers and sorting strategies to generate pure populations
of viable NSC55, and the difficulty of apply ultrastructural approaches
dictated our approach to next demonstrate a regulatory role for GH/
GHR on endogenous NSCs. We began by showing that deletion of
the receptor results in fewer NSC-derived colonies being detected
(Fig. 4A), while the infusion of GH results in the activation and
associated increase in the number of endogenous NSCs (Fig. 4B).
Interestingly, as part of our infusion studies we unexpectedly found
that in contrast to similar infusions of the mitogens EGF53 or bFGF
(Fig. 4C), the short-term infusion of GH resulted in a significant and
sustained elevation in the number of endogenous NSCs a response
not previously observed with any growth factor. While outside of the
scope of this study, further study is warranted to determine whether
these unexpected results reflect an alteration in the phenotype and/or
function of these GH-responsive cells, and the physiological conse-
quences of such a change.
To provide additional in vivo evidence of a functional role for GH
in the regulation of endogenous NSCs we undertook a series of SVZ
ablation/regeneration studies, using both in vitro (i.e. neurosphere
and N-CFCA assays) and in vivo assays (immunocytochemistry) as
readouts of stem and progenitor cell activity. Based on earlier stud-
ies2,51,52, we predicted that if GH was activating normally quiescent
NSCs, these activated NSCs would be ablated by subsequent irra-
diation, resulting in fewer NSC-derived colonies, and a diminished
regenerative response. Indeed, this was the case. Consistent with
previous reports2,50, those animals whose endogenous stem cells were
not activated (i.e. saline and EGF-infused mice) prior to irradiation
exhibited a complete repopulation (to pre-irradiation levels) of the
BrdU1ve (Fig. 5A) and neurosphere forming (Fig 5C) cells in the SVZ
by 3 weeks post-irradiation. However, those animals in which qui-
escent NSCs were activated prior to irradiation (GH-infused, and
‘‘double dose’’ mice, failed to repopulate either BrdU1ve or neuro-
sphere forming cells to pre-irradiation levels by 3 weeks. Of interest,
the repopulation of ‘‘double dose’’ mice reached pre-irradiation
levels, but took approximately double the time to complete, dem-
onstrating that the radiation-induced depletion of the PVR in itself is
not sufficient cause incomplete repopulation.
Finally, we examined the effect GH infusion would have on OB
neurogenesis. This approach was based on the finding that SVZ
NSCs (Type B cells) represent the ultimate source of newly-generated
OB interneurons10. Consistent with GH activating Type B cells, we
found that an acute ICV infusion of GH increased the number of new
neurons in the OB, while the irradiation-induced ablation of GH-
activatedNSCs resulted in a significant reduction both in the number
of BrdU1ve cells and newly generated neurons in the OB.
Taken together, these results suggest that GHRs are present on a
population of endogenous NSCs, where they regulate the activity of
these cells.
Figure 6 | GH-dependent alteration of olfactory bulb neurogenesis. (A) No significant difference was apparent in the number of BrdU1ve cells detected
in the OB 28 days after the 7-day ICV infusion of either GH or saline. In contrast, a significantly greater number of BrdU1ve/NeuN1ve cells was detected in
the OB of GH- versus saline-infused mice (1455637 vs. 8696140, p 5 0.008, n 5 3). (B) Significantly fewer BrdU1ve cells were detected in the OB of
GH-infused mice following irradiation as compared to saline-infused controls (6265 vs. 273650, p 5 0.007, n 5 3). Likewise, the number of
BrdU1ve/NeuN1ve cells detected in the OB of GH- versus saline-infused controls was also significantly reduced (2164 vs. 63612, p 5 0.014, n 5 3).
**p,0.01.
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It has become apparent that stem cell numbers in a variety of
tissues decline as part of the aging process, and are unable to main-
tain tissue homeostasis at youthful levels56. It is plausible that activ-
ating a cohort of NSCs by GH infusion could lead to a long-term
temporal extension of functional tissue homeostasis. This could be a
powerful therapeutic in countering age-related decline in regenerat-
ive capacity and cognitive function, as this progressive loss also cor-
relates with the age-dependent decline in GH secretion in rodents
and humans33. Independent of its potential therapeutic value, invest-
igation into the mechanism by which NSC numbers are altered will
undoubtedly increase our understanding of how the brain responds
to its environment.
Methods
Tissue processing. Animals were treated in accordance with the Australian Code of
Practice for the Care and Use of Animals for Scientific Purposes, and all experiments
were approved by The University of Queensland Animal Ethics Committee. Adult
(6–8 weeks old) male and female C57BL/6J mice were deeply anesthetized with
sodium pentobarbitone (260 mg/kg), and then transcardially perfused with ice-cold
0.9% saline followed by 4.0% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4).
Brains were harvested, post-fixed, and cryoprotected, as previously described57. Serial
frontal sections (14 mm) were cut with a MICROM cryostat, mounted on SuperFrost
Plus slides (SuperFrost Plus), dried at room temperature (RT) and stored at 220uC
until processed. Every second section was collected from the rostral tip of the OB to
Bregma (12.58 mm) for examination of the OB, and from the onset of the lateral
ventricle (11.42 mm) to the joining of the anterior commissure (10.14 mm) for
examination of the lateral ventricles.
In all cases, tissue sections were initially rinsed in PBS (335 minutes) before
incubation in blocking solution (5% fetal bovine serum (JRH Biosciences, USA) plus
5% normal goat serum (Sigma-Aldrich, USA) in 0.1 M PBS 1 0.2% Triton (Sigma-
Aldrich)) for 60 minutes at RT.
Tissue sections were processed for the detection of bromodeoxyuridine (BrdU) or
dual-label BrdU/anti-neuronal nuclei (NeuN, 1560; Chemicon, USA, MAB377.
GHR1ve cells were detected on fixed tissue using anti-GHR (15300; Santa Cruz, USA,
SC-20747 which labels an intracellular portion of the GHR). Note: specificity of the
anti-GHR antibody was verified by an absence of immunoreactivity on tissue sections
harvested from GHR2/2 mice. For all GHR dual-label immunocytochemistry, sec-
tions were incubated with anti-GHR (SC-20747) and anti-Ki67 (1560; Novacastra,
UK, NCL-L-Ki67-MM1), anti-glial fibrillary acidic protein (GFAP, 15300;
Chemicon, MAB360), anti-NeuN (15100; Chemicon, MB377), anti-Nestin (15500;
Abcam, AB6142), anti-PDGFRa (15300, Abcam, AB69506) anti-PSA-NCAM
(15200; Chemicon, MAB5324), and anti-CD133 (15100; Abcam, AB27699), diluted
in blocking solution and incubated overnight at 4uC. Sections were washed three
times with PBS and then incubated for 60 minutes (RT) with the appropriate sec-
ondary antibodies (15300; Alexa Fluor goat anti-rabbit-488 for anti-GHR and
151000; Alexa Fluor goat anti-mouse-568 for remaining antibodies; Molecular
Probes, USA) plus 49,6-diamidino-2-phenylindole (DAPI, 151000, Sigma-Aldrich).
Sections were then washed three times with PBS and once in dH20, before being
coverslipped with fluorescent mounting medium (DakoCytomation, USA). Images
were captured using a Zeiss Axioimager Z1 with Apotome and Axiocam MRm
software (Zeiss, Germany).
Intracerebroventricular (ICV) infusions. Twelve hours prior to surgery, osmotic
mini pumps (Alzet, #1007D; 7 day infusion at 0.5 ml/hour) were loaded with GH (10
mg/ml, recombinant rat, GroPep Australia), bFGF (20 mg/ml, human recombinant,
Stem Cell Technologies, Canada), EGF (40 mg/ml, Stem Cell Technologies) or vehicle
solution (0.9% sterile physiological saline, Sigma-Aldrich), and attached to the
infusion cannula. Although the physiological concentration of GH in the cerebral
spinal fluid ofmice is unknown, a previous study27 carried out a single ICV infusion in
rats of 20 mg/ml, thus we reasoned that a conservative dose of 5 ng/hour of GH should
mimic endogenous levels in the mouse. Details of the infusion protocol are given in
Blackmore et al. 2009. A separate cohort of GH- and vehicle-infused mice received a
single 150 ml intraperitoneal (i.p.) injection of BrdU (9 mg/ml, 45 mg/kg body
weight), dissolved in 0.07 N NaOH in 0.9% NaCl; Sigma-Aldrich) 2 hours prior to
the completion of the infusion period, and were subsequently sacrificed 28 days later.
Irradiation. Mice were restrained within a plastic chamber and placed in a lead-
shielded container leaving only the head exposed for irradiation. Single or ‘‘double-
dose’’ irradiation was induced by exposure to a Co60 source in a Gamma Cell 200
irradiator until a 3.5Gy dose had been given. The PVRwas harvested fromGH-, EGF-
and vehicle-infused animals at 24 hours, 1-, 3- or 6-weeks post-irradiation and
cultured in the neurosphere assay (described below). In addition, a second cohort of
GH- and vehicle-infused mice received a single injection of BrdU (as above) 2 hours
prior to sacrifice, after which the brain was removed, sectioned, and processed for the
detection of BrdU1ve cells. For OB experiments, owing to the irradiation-induced loss
of dividing cells, cohorts of GH- and vehicle-infused mice received a total of five
BrdU injections (as above) over a period of 10 hours, 14 days post-infusion. These
mice were irradiated 48-hours after the last BrdU injection and sacrificed 28 days
post-irradiation.
Primary neurosphere cultures. Adult (6–8 week old) mice (C57Bl/6J or GHR2/2 on
this background) were sacrificed by cervical dislocation, their brains removed
immediately, and transferred to Petri dishes containing HEPES-buffered minimum
essential medium (HEM). Full details of the protocol are given in Blackmore et al.
2009.
Neurosphere passaging and differentiation markers. Adult neurospheres were
collected by centrifugation (5 minutes at 100 g rcf), after which they were
resuspended and incubated in 0.1% trypsin-EDTA for 4minutes before being washed
with trypsin inhibitor in neurosphere media (NS media). Adult neurosphere cultures
were passaged every 7 days in vitro (DIV) in EGF (20 ng/ml) containing complete
medium either with or without rat GH (100 ng/ml). For differentiation, neurospheres
were plated at time of passage onto poly-L-ornithine (Sigma-Aldrich) coated glass
coverslips in NeuroCultTM NSC Basal Medium plus Proliferation Supplements (Stem
Cell Technologies) without 1% fetal calf serum for 7 days. The differentiated
neurospheres were then fixed with 4% paraformaldehyde in 0.1 M PBS at RT for 15
minutes, rinsed three times with PBS, and incubated with anti-O4 (Clone 81, IgM,
BoehringerMannheim, Germany) diluted 1550with PBS/10%normal goat serum for
2 hours at 37uC. Cells were then rinsed three times with PBS and incubated with
FITC-conjugated goat-anti-mouse IgM (15200, Molecular Probes) for 30 minutes at
37uC. Cells were again rinsed in PBS (335minutes) before incubation with anti-bIII-
tubulin (mouse monoclonal IgG, 151500, Chemicon) 1 anti-GFAP (rabbit
polyclonal, 15500, DakoCytomation) diluted in PBS/0.3% Triton/10% normal goat
serum for 120 minutes at 37uC. Again, cells were rinsed in PBS (335 minutes) and
then incubated with goat-anti-mouse-CY3 and goat-anti-rabbit-AMCA (both 15200,
Molecular Probes) diluted in MTPBS/10% NGS at 37uC for 30 minutes. Finally, cells
were rinsed (335 minutes in PBS) andmounted using Fluorsave (DakoCytomation).
Neural colony forming cell assay. Primary tissue was dissociated and the number of
viable cells determined as per the primary neurosphere cultures (see above).
Neurosphere-derived cells were cultured in 35 mm cell culture dishes with a 2 grid
(Nunc, USA) at a density recommended for the mouse NeuroCultTM Neural Colony
Forming Cell Assay (Stem Cell Technologies). Cells were incubated for 21 DIV in 5%
CO2 with appropriate growth factors (either EGF alone or EGF 1GH) being added
every 7 days. After 21 DIV, the total number of colonies and the diameter of each
colony was determined using an eyepiece graticule on an inverted Leica light
microscope with phase contrast.
Flow cytometry. Single cell suspensions were generated from tissue and sorted for
surface growth hormone binding protein (GHBP) expression using an anti-GHBP
antibody (BETO 8041)48. Murine GHBP consists of a ligand-binding domain that is
identical to the extracellular portion of the GHR, together with a short C-terminal
sequence coded by an alternate exon. For immunostaining, cell suspensions were
incubated in NS basal medium with anti-GHBP48 (15100) for 15 minutes at 4uC. Cell
suspensions were rinsed via centrifugation (7 minutes at 100 g rcf), and then
incubated in blocking solution containing Alexa Fluor 488 conjugated goat-anti-
rabbit IgG antibody (151000; Molecular Probes) for 30 minutes at RT. The cell
suspension(s) were then rinsed in PBS 1 propidium iodide (100 mg/ml; Molecular
Probes) before cell sorting. Cells were sorted using a FACSVantage SEDiVA (Becton,
Dickinson, USA) with data analysis performed using FlowJo 6 (TreeStar Inc., USA)
software. Cell to event ratios were determined for each population by seeding 500
events into individual wells of a 96-well plate, then visually scoring cells,1 hour after
plating. All cells were collected directly into 35 mm dishes containing NSA1EGF
(and GHwhere appropriate) and incubated at 37uC in a 5%CO2 incubator. Images of
fixed GHR-IR cells were captured using an AMNIS Image Stream Analyzer (AMNIS,
USA).
qRT-PCR. RNA was extracted using TRIZOLH (Invitrogen, USA) and cDNA was
made using Superscript IIIH (Invitrogen). TaqMAN qRT PCR was undertaken with
specific GHR primers for the cytoplasmic domain provided fromApplied Biosystems
TaqManHGene Expression Assays (ID #Mm00439093-m1). cDNA was diluted 155
and samples were normalized to 18S rRNA.
Statistical Analysis. Factorial design analysis of variance (ANOVA) or Student’s two-
tailed unpaired t-tests were used to analyze data as appropriate. Significant ANOVA
values were followed by post hoc comparisons of individual means using the Tukey
multiple comparisons test where appropriate. All values are expressed as mean 6
SEM unless otherwise indicated with significance for all comparisons p,0.05.
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